Compare BLCO & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | TRNO |
|---|---|---|
| Founded | 1853 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 6.0B |
| IPO Year | 2022 | 2010 |
| Metric | BLCO | TRNO |
|---|---|---|
| Price | $17.35 | $59.60 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 13 |
| Target Price | $17.31 | ★ $65.00 |
| AVG Volume (30 Days) | 350.5K | ★ 633.8K |
| Earning Date | 02-18-2026 | 02-04-2026 |
| Dividend Yield | N/A | ★ 3.50% |
| EPS Growth | N/A | ★ 75.67 |
| EPS | N/A | ★ 3.15 |
| Revenue | ★ $4,976,000,000.00 | $442,611,000.00 |
| Revenue This Year | $8.06 | $22.96 |
| Revenue Next Year | $5.79 | $10.44 |
| P/E Ratio | ★ N/A | $18.89 |
| Revenue Growth | 6.23 | ★ 21.13 |
| 52 Week Low | $10.45 | $48.18 |
| 52 Week High | $18.14 | $69.20 |
| Indicator | BLCO | TRNO |
|---|---|---|
| Relative Strength Index (RSI) | 59.33 | 47.41 |
| Support Level | $17.02 | $57.95 |
| Resistance Level | $17.55 | $60.45 |
| Average True Range (ATR) | 0.41 | 1.08 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 70.12 | 52.02 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.